Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
![](https://fprimecapital.com/wp-content/uploads/2019/01/alternate-healthcare-illustration-1024x1024.jpg)
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
PR Newswire
Innovent and Laekna Therapeutics Enter a Partnership Agreement to Co-Develop Combination Therapy of Sintilimab and Afuresertib in Clinical Studies in China
July 5, 2021 -
Renaissance Capital Report
Cell analysis instruments provider Cytek BioSciences files for a $100 million IPO
July 2, 2021 -
Business Wire
Rallybio Announces Clinical Proof of Concept for RLYB211, an Anti-HPA-1a Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
July 2, 2021 -
GlobeNewswire
Significant Continued Progress with Formulary Uptake of BARHEMSYS® and BYFAVO™ in the US
July 1, 2021 -
MarketWatch
Caribou Biosciences files for IPO to help fund drug studies
July 1, 2021 -
GlobeNewswire
Orchard Therapeutics and Pharming Group Announce Collaboration to Develop and Commercialize ex vivo autologous HSC Gene Therapy for Hereditary Angioedema
July 1, 2021 -
GlobeNewswire
Apellis and Beam Therapeutics Enter Exclusive Research Collaboration to Apply Base Editing to Discover Novel Therapies for Complement-Driven Diseases
June 30, 2021 -
GlobeNewswire
Carrot Fertility and RESOLVE Uncover Fertility and Family-Forming Trends in New Fertility at Work Study
June 30, 2021 -
GlobeNewswire
Ultragenyx Appoints Corsee Sanders, Ph.D., to Board of Directors
June 30, 2021 -
Business Wire
Turnstone Biologics Appoints Stewart Abbot, Ph.D., as Chief Scientific Officer
June 29, 2021 -
Business Wire
Precision BioSciences and SpringWorks Therapeutics Dose First Patient in Expanded Phase 1/2a Clinical Trial Evaluating PBCAR269A with Nirogacestat in Patients with Relapsed/Refractory Multiple Myeloma
June 28, 2021 -
PR Newswire
Protenus Announces Nick Culbertson Is an EY Entrepreneur of the Year® 2021 Mid-Atlantic Award Finalist
June 28, 2021 -
PR Newswire
Innovent Announces License Agreement with Synaffix in an ADC Technology Deal
June 28, 2021 -
GlobeNewswire
Denali Therapeutics Announces Initiation of Phase 2 Study by Partner Sanofi of RIPK1-Inhibitor DNL758 (SAR443122) in Cutaneous Lupus Erythematosus (CLE) Patients
June 28, 2021 -
PR Newswire
Innovent Announces the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma
June 27, 2021 -
PR Newswire
Innovent Announces the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with BYVASDA® (bevacizumab biosimilar injection) as First-Line Therapy for People with Hepatocellular Carcinoma
June 27, 2021 -
FierceBiotech
Boston Scientific shells out a hearty $295M for Farapulse’s electric-field-generating afib treatment
June 24, 2021 -
GlobeNewswire
Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases
June 23, 2021 -
PR Newswire
Innovent Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market for the Treatment of Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with a FGFR2 Fusion or Rearrangement
June 21, 2021 -
GlobeNewswire
Verve Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 21, 2021 -
Business Wire
Xilio Therapeutics Announces FDA Acceptance of IND Application for XTX101 for the Treatment of Solid Tumors
June 17, 2021 -
Economic Times
PharmEasy valued at $1.8 billion as B Capital buys stake for $20 million
June 17, 2021 -
MarketWatch
Verve Therapeutics shares soar 68% in trading debut
June 17, 2021 -
Business Wire
Zus Health Closes $34M Series A Led by Andreessen Horowitz (a16z); Participation from F-Prime Capital, Maverick Ventures and Others
June 17, 2021 -
PR Newswire
FDA Approves Blueprint Medicines’ AYVAKIT™ (avapritinib) for the Treatment of Adults with Advanced Systemic Mastocytosis
June 16, 2021 -
PR Newswire
Protenus Raises Series D After Doubling Revenue While Reducing Risk for Health Systems
June 15, 2021 -
PR Newswire
Innovent Announces First Overweight or Obese Subject Dosed in A Phase 2 Clinical Trial of IBI362 (a GLP-1 and Glucagon Receptor Dual Agonist) in China
June 15, 2021 -
Business Wire
Iora Health and Devoted Health Partner in Houston
June 14, 2021 -
Seeking Alpha
Verve Therapeutics Prepares $201 Million IPO
June 14, 2021 -
Business Wire
Equality Health Launches Partnership with Devoted Health
June 14, 2021 -
GlobeNewswire
GeneTx and Ultragenyx Receive Approval from U.K. Regulatory Agency to Begin Clinical Study of GTX-102 for the Treatment of Angelman Syndrome
June 10, 2021 -
One Medical
One Medical Announces Agreement to Acquire Iora Health
June 7, 2021 -
Forbes
Beam Therapeutics Cofounder And Crispr Scientist Publishes Research On New Sickle Cell Treatment In Mice
June 2, 2021 -
PR Newswire
Clinical Trial Results of the BCMA CAR-T Co-developed by Innovent and IASO Biotherapeutics Commented in American Society of Hematology’s Medical Journal “Blood”
June 2, 2021 -
GlobeNewswire
Zenflow Announces $24 Million Financing Round; Appoints Susan Stimson as President
June 2, 2021 -
Business Wire
Verve Therapeutics Appoints Leading Biotechnology Executive Michael MacLean to its Board of Directors
June 1, 2021 -
PR Newswire
Owkin Bolsters Senior Team With Experienced Pharma Executives to Expand Platform and Strategic Partnerships
June 1, 2021 -
Business Wire
Precision BioSciences Announces New Study Published in Nature Communications Using Engineered ARCUS Nuclease to Target Mutant Mitochondrial DNA In Vivo
June 1, 2021 -
PR Newswire
Innovaccer Partners With PatientPing to Empower Physicians With Real-Time Care Coordination
June 1, 2021 -
GlobeNewswire
AnHeart Therapeutics and Innovent Biologics Announce Exclusive License Agreement for Taletrectinib in Greater China
May 31, 2021 -
Renaissance Capital Report
Gene editing biotech Verve Therapeutics files for a $100 million IPO
May 28, 2021 -
GlobeNewswire
Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945
May 27, 2021 -
PR Newswire
NFlection Therapeutics’ NFX-179 Gel Demonstrates Safety and Significant Reduction in p-ERK, a Key Biomarker Driving Neurofibroma Tumor Growth, in Positive Data From a 28-Day Phase 2a Clinical Trial
May 26, 2021 -
GlobeNewswire
Singular Genomics Systems, Inc. Announces Pricing of Upsized Initial Public Offering of Common Stock
May 26, 2021 -
GlobeNewswire
Apellis and Sobi Report Positive Top-line Results from the Phase 3 PRINCE Study of EMPAVELI™ (pegcetacoplan) in Treatment-naïve Patients with PNH
May 25, 2021 -
Business Wire
Xilio Therapeutics Announces Clinical Trial Collaboration With Merck on Anti-CTLA-4 Monoclonal Antibody Program
May 25, 2021 -
PR Newswire
Innovent Announces First Patient Dosed in China in the Global Phase 3 Clinical Trial of Pemigatinib as the First-line Treatment of Unresectable or Metastatic Cholangiocarcinoma
May 24, 2021 -
Business Wire
Xilio Therapeutics to Present Preclinical Data Highlighting Anti-Tumor Activity and Tolerability of XTX202 at the 2021 ASCO Annual Meeting
May 20, 2021 -
GlobeNewswire
GeneTx and Ultragenyx Receive Clearance from Health Canada to Begin Clinical Study of GTX-102 in Canada for the Treatment of Angelman Syndrome
May 19, 2021 -
GlobeNewswire
Adagene Presents Clinical Data from NEObody™ Program, ADG106, Anti-CD137 Agonist, in an Abstract at ASCO 2021 Annual Meeting
May 19, 2021 -
FierceBiotech
ASCO: Adaptimmune’s cell therapy shrinks 39% of rare sarcomas
May 19, 2021 -
PR Newswire
U.S. FDA Accepts Regulatory Submission for Sintilimab in Combination with Pemetrexed and Platinum Chemotherapy for the First-Line Treatment of People with Nonsquamous Non-Small Cell Lung Cancer
May 18, 2021 -
PR Newswire
LunaPBC Announces Joe Beery as New Chief Executive Officer
May 18, 2021 -
PR Newswire
Protenus Selected as One of the Best Places to Work in Healthcare for Fourth Straight Year
May 17, 2021 -
Business Wire
Caribou Biosciences Announces Appointment of Katy Rezvani, M.D., Ph.D. and Christopher Sturgeon, Ph.D. to its Scientific Advisory Board
May 17, 2021 -
PR Newswire
Innovent Will Publish Multiple Clinical Data at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting
May 16, 2021 -
GlobeNewswire
Ultragenyx Announces Positive Multi-Year Durability Data from Ongoing Phase 1/2 Gene Therapy Studies and Data on HeLa 3.0 Manufacturing Platform at American Society of Gene & Cell Therapy 2021 Annual Meeting
May 14, 2021 -
GlobeNewswire
Apellis Announces U.S. Food and Drug Administration (FDA) Approval of EMPAVELI™ (pegcetacoplan) for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
May 14, 2021 -
GlobeNewswire
Affinia Therapeutics Presents New Data and Updates on AAV Platform at American Society of Gene and Cell Therapy Annual Meeting
May 13, 2021 -
Business Wire
Xilio Therapeutics Presents Preclinical Tumor-Selective Activity and Tolerability Data for XTX101 at Frontiers in Cancer Immunotherapy Virtual Symposium
May 12, 2021 -
PR Newswire
Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)
May 12, 2021 -
GlobeNewswire
First Preclinical Data from Adaptimmune’s Mesothelin HiT Program at ASGCT Demonstrate Antigen-specific Tumor Cell Killing in vitro and Complete Tumor Regression in an Animal Model
May 11, 2021 -
GlobeNewswire
Orchard Therapeutics Announces New England Journal of Medicine Publication of HSC Gene Therapy Data for ADA-SCID
May 11, 2021 -
GlobeNewswire
Beam Therapeutics Presents LNP Formulation Data at ASGCT and Reports First Quarter 2021 Financial Results
May 11, 2021 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Clinical Supply Agreement with Regeneron to Evaluate Vidutolimod (CMP-001) in Combination with Libtayo® (cemiplimab)
May 10, 2021 -
Renaissance Capital Report
Singular Genomics Systems, a developer of next-gen sequencing tech, files for a $100 million IPO
May 7, 2021 -
Business Wire
Turnstone Biologics Announces Executive Leadership Promotions and Board Appointment
May 7, 2021 -
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
May 6, 2021 -
Business Wire
Caribou Biosciences Announces Appointment of Industry Leader Andrew Guggenhime to its Board of Directors
May 5, 2021 -
Business Wire
Verve Therapeutics Appoints Industry Leader Sheila Mikhail to its Board of Directors
May 5, 2021 -
Business Wire
Xilio Therapeutics Appoints Christina Rossi to Its Board of Directors
May 5, 2021 -
PR Newswire
Protenus’ 5th Annual PANDAS Conference Cultivates Innovation and Compliance Best Practices Throughout COVID-19 Pandemic
May 5, 2021 -
GlobeNewswire
Checkmate Pharmaceuticals Announces Initiation of Patient Dosing in Potential Registration Trial of Vidutolimod (CMP-001) in Patients with Anti-PD-1 Refractory Advanced Melanoma
May 4, 2021 -
PR Newswire
Centivo launches new health plan for self-funded employers in Iowa utilizing Incirca Health Network, powered by MercyOne
May 4, 2021 -
GlobeNewswire
Affinia Therapeutics Closes $110 Million Series B Financing
May 3, 2021 -
GlobeNewswire
Denali Therapeutics Presents Positive Results from Phase 1 and Phase 1b Studies of Its LRRK2 Inhibitor, BIIB122/DNL151, Supporting Late-Stage Development Plans in Parkinson’s Disease
May 1, 2021 -
PR Newswire
Carrot Fertility and Legacy Partner to Expand Access to Male Fertility Care
April 28, 2021 -
PR Newswire
Announcing 1upHealth’s $25 million Series B led by F-Prime
April 28, 2021 -
PR Newswire
Innovent Announces First Patient Dosed in the Phase 2 Clinical Trial of IBI302, a First-in-class Ophthalmic Anti-VEGF and Anti-Complement Bispecific Fusion Protein for Neovascular Age-Related Macular Degeneration
April 28, 2021 -
GlobeNewswire
Sana Biotechnology to Present Pre-Clinical Data at American Society of Gene & Cell Therapy Annual Meeting 2021
April 27, 2021 -
Business Today
Dental software start-up CareStack raises $22.5 million to fund expansion
April 27, 2021 -
GlobeNewswire
Ultragenyx Completes Successful End-of-Phase 2 Meeting with FDA and Finalizes Phase 3 Study Design for DTX301 Ornithine Transcarbamylase (OTC) Gene Therapy Program
April 22, 2021 -
PR Newswire
Papaya Announces Tools for Best-in-Class Employee Experience
April 21, 2021 -
Sifted
Proximie raises $38m for augmented reality surgery
April 21, 2021 -
GlobeNewswire
Beam Therapeutics Publishes Data Highlighting Ability to Rationally Design Base Editors for Precise Editing
April 20, 2021 -
PR Newswire
Citrine Medicine and Sinopharm Group Announce Strategic Partnership to Broaden and Accelerate Access to Rare Disease Drugs in China
April 19, 2021 -
Forbes
This Startup Raised $25 Million To Liberate Your Healthcare Data In The Cloud
April 14, 2021 -
PR Newswire
Former Blackboard VP of Engineering to Join Protenus
April 13, 2021 -
PR Newswire
Benchling Appoints Krista Anderson-Copperman to Its Board of Directors
April 13, 2021 -
GlobeNewswire
Adagene Presents Preclinical Data from Lead SAFEbody™ Program, ADG126, at the American Association for Cancer Research (AACR) Annual Meeting 2021
April 13, 2021
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.